AstraZeneca
AZN
AZN
978 hedge funds and large institutions have $34.2B invested in AstraZeneca in 2022 Q1 according to their latest regulatory filings, with 120 funds opening new positions, 343 increasing their positions, 298 reducing their positions, and 78 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
3% more funds holding
Funds holding: 945 → 978 (+33)
10% more call options, than puts
Call options by funds: $495M | Put options by funds: $450M
0.8% more ownership
Funds ownership: 32.53% → 33.34% (+0.8%)
Holders
978
Holding in Top 10
17
Calls
$495M
Puts
$450M
Top Buyers
| 1 | +$350M | |
| 2 | +$291M | |
| 3 | +$218M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$165M |
| 5 |
1832 Asset Management
Toronto,
Ontario, Canada
|
+$140M |
Top Sellers
| 1 | -$462M | |
| 2 | -$166M | |
| 3 | -$90.5M | |
| 4 |
Renaissance Technologies
New York
|
-$83.4M |
| 5 |
Legal & General Group
London,
United Kingdom
|
-$81.1M |